Thrombotic microangiopathy associated with lenvatinib therapy
Systemic thrombotic microangiopathy (TMA) is a serious condition whose early treatment is essential to reduce morbidity and mortality. TMA with only renal involvement has been associated with tyrosine kinase inhibitors, including lenvatinib, a drug used for certain advanced neoplasms. To date, TMA w...
Furkejuvvon:
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Bioscientifica
2023-04-01
|
| Ráidu: | Endocrine Oncology |
| Fáttát: | |
| Liŋkkat: | https://eo.bioscientifica.com/view/journals/eo/3/1/EO-22-0078.xml |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|